Principles of pharmacoeconomics:
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cincinnati, OH
Harvey Whitney Books
2005
|
| Ausgabe: | 3. ed. |
| Schlagworte: | |
| Beschreibung: | X, 409 S. graph. Darst. |
| ISBN: | 0929375270 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV019669299 | ||
| 003 | DE-604 | ||
| 005 | 20050718 | ||
| 007 | t | ||
| 008 | 050124s2005 d||| |||| 00||| eng d | ||
| 020 | |a 0929375270 |9 0-929375-27-0 | ||
| 035 | |a (OCoLC)56898826 | ||
| 035 | |a (DE-599)BVBBV019669299 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RM263 | |
| 082 | 0 | |a 338.4/36151 |2 22 | |
| 084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
| 084 | |a QX 740 |0 (DE-625)142192: |2 rvk | ||
| 100 | 1 | |a Bootman, J. Lyle |e Verfasser |0 (DE-588)129516694 |4 aut | |
| 245 | 1 | 0 | |a Principles of pharmacoeconomics |c J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan |
| 250 | |a 3. ed. | ||
| 264 | 1 | |a Cincinnati, OH |b Harvey Whitney Books |c 2005 | |
| 300 | |a X, 409 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Chimiothérapie - Aspect économique | |
| 650 | 4 | |a Industrie pharmaceutique | |
| 650 | 4 | |a Médicaments - Politique gouvernementale | |
| 650 | 4 | |a Chemotherapy |x Economic aspects | |
| 650 | 4 | |a Cost-Benefit Analysis | |
| 650 | 4 | |a Decision Support Techniques | |
| 650 | 4 | |a Drug Therapy |x economics | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Pharmaceutical policy | |
| 650 | 4 | |a Pharmacology |x economics | |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | 1 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 1 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 2 | 1 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Townsend, Raymond J. |d 1991- |e Verfasser |0 (DE-588)138534012 |4 aut | |
| 700 | 1 | |a McGhan, William F. |e Verfasser |0 (DE-588)129516686 |4 aut | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012997555 | ||
Datensatz im Suchindex
| _version_ | 1804133052067086336 |
|---|---|
| any_adam_object | |
| author | Bootman, J. Lyle Townsend, Raymond J. 1991- McGhan, William F. |
| author_GND | (DE-588)129516694 (DE-588)138534012 (DE-588)129516686 |
| author_facet | Bootman, J. Lyle Townsend, Raymond J. 1991- McGhan, William F. |
| author_role | aut aut aut |
| author_sort | Bootman, J. Lyle |
| author_variant | j l b jl jlb r j t rj rjt w f m wf wfm |
| building | Verbundindex |
| bvnumber | BV019669299 |
| callnumber-first | R - Medicine |
| callnumber-label | RM263 |
| callnumber-raw | RM263 |
| callnumber-search | RM263 |
| callnumber-sort | RM 3263 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | QX 700 QX 740 |
| ctrlnum | (OCoLC)56898826 (DE-599)BVBBV019669299 |
| dewey-full | 338.4/36151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/36151 |
| dewey-search | 338.4/36151 |
| dewey-sort | 3338.4 536151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| edition | 3. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02297nam a2200625 c 4500</leader><controlfield tag="001">BV019669299</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050718 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050124s2005 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0929375270</subfield><subfield code="9">0-929375-27-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)56898826</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019669299</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM263</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/36151</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 740</subfield><subfield code="0">(DE-625)142192:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bootman, J. Lyle</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129516694</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Principles of pharmacoeconomics</subfield><subfield code="c">J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cincinnati, OH</subfield><subfield code="b">Harvey Whitney Books</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 409 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chimiothérapie - Aspect économique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Politique gouvernementale</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemotherapy</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cost-Benefit Analysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Decision Support Techniques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Therapy</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Townsend, Raymond J.</subfield><subfield code="d">1991-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)138534012</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McGhan, William F.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129516686</subfield><subfield code="4">aut</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012997555</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV019669299 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:02:35Z |
| institution | BVB |
| isbn | 0929375270 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012997555 |
| oclc_num | 56898826 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | X, 409 S. graph. Darst. |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | Harvey Whitney Books |
| record_format | marc |
| spelling | Bootman, J. Lyle Verfasser (DE-588)129516694 aut Principles of pharmacoeconomics J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan 3. ed. Cincinnati, OH Harvey Whitney Books 2005 X, 409 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Chimiothérapie - Aspect économique Industrie pharmaceutique Médicaments - Politique gouvernementale Chemotherapy Economic aspects Cost-Benefit Analysis Decision Support Techniques Drug Therapy economics Pharmaceutical industry Pharmaceutical policy Pharmacology economics Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Gesundheitsökonomie (DE-588)4130935-2 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Pharmakotherapie (DE-588)4076066-2 s Gesundheitsökonomie (DE-588)4130935-2 s DE-604 Kosten-Nutzen-Analyse (DE-588)4032589-1 s Arzneimittelentwicklung (DE-588)4143176-5 s Townsend, Raymond J. 1991- Verfasser (DE-588)138534012 aut McGhan, William F. Verfasser (DE-588)129516686 aut |
| spellingShingle | Bootman, J. Lyle Townsend, Raymond J. 1991- McGhan, William F. Principles of pharmacoeconomics Chimiothérapie - Aspect économique Industrie pharmaceutique Médicaments - Politique gouvernementale Chemotherapy Economic aspects Cost-Benefit Analysis Decision Support Techniques Drug Therapy economics Pharmaceutical industry Pharmaceutical policy Pharmacology economics Pharmakotherapie (DE-588)4076066-2 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4032589-1 (DE-588)4130935-2 (DE-588)4143176-5 (DE-588)4143413-4 |
| title | Principles of pharmacoeconomics |
| title_auth | Principles of pharmacoeconomics |
| title_exact_search | Principles of pharmacoeconomics |
| title_full | Principles of pharmacoeconomics J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan |
| title_fullStr | Principles of pharmacoeconomics J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan |
| title_full_unstemmed | Principles of pharmacoeconomics J. Lyle Bootman ; Raymond J. Townsend ; William F. McGhan |
| title_short | Principles of pharmacoeconomics |
| title_sort | principles of pharmacoeconomics |
| topic | Chimiothérapie - Aspect économique Industrie pharmaceutique Médicaments - Politique gouvernementale Chemotherapy Economic aspects Cost-Benefit Analysis Decision Support Techniques Drug Therapy economics Pharmaceutical industry Pharmaceutical policy Pharmacology economics Pharmakotherapie (DE-588)4076066-2 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Chimiothérapie - Aspect économique Industrie pharmaceutique Médicaments - Politique gouvernementale Chemotherapy Economic aspects Cost-Benefit Analysis Decision Support Techniques Drug Therapy economics Pharmaceutical industry Pharmaceutical policy Pharmacology economics Pharmakotherapie Kosten-Nutzen-Analyse Gesundheitsökonomie Arzneimittelentwicklung Aufsatzsammlung |
| work_keys_str_mv | AT bootmanjlyle principlesofpharmacoeconomics AT townsendraymondj principlesofpharmacoeconomics AT mcghanwilliamf principlesofpharmacoeconomics |